Key result
The Sorin Mitroflow bovine pericardial valve demonstrated significantly lower mean transvalvular pressure gradients compared to the St. Jude Medical Epic porcine valve at 1 and 5 years postoperatively.
Why the study?
The choice between porcine and pericardial tissue valves for bioprosthetic aortic valve replacement remains complex, prompting an evaluation of their hemodynamic and clinical differences.
Does the Sorin Mitroflow bovine pericardial valve improve postoperative hemodynamic performance compared to the St. Jude Medical Epic Supra porcine valve in patients undergoing surgical aortic valve replacement?
Cohort (n=71)
No
Does the Sorin Mitroflow bovine pericardial valve improve postoperative hemodynamic performance compared to the St. Jude Medical Epic Supra porcine valve in patients undergoing surgical aortic valve replacement?
Answers are grounded in this paper and cite their sources.
Bovine pericardial valves demonstrated superior hemodynamic performance with lower transvalvular gradients compared to porcine valves up to 5 years post-surgery, though both provided excellent clinical improvement and similar mid-term survival.
Summary The choice between mechanical and bioprosthetic aortic valve implants is affected by relatively clear criteria. However, the choice between porcine or pericardial valve is more complex regarding bioprosthetic devices. We aimed to elucidate any hemodynamic and clinical difference between two widely used bioprosthetic valves: the Sorin Mitroflow bovine pericardial valve and the St. Jude Medical Epic Supra porcine valve. We retrospectively studied 71 consecutive patients separated into two groups based on the valve they received. Clinical outcomes included patient survival and hemodynamic performance of the implanted prostheses. Patients were assessed at one and five years postoperatively. Mean transprosthetic pressure gradients were used as a marker of hemodynamic performance. The Mitroflow valve exhibited lesser mean transvalvular gradients than the Epic valve for all labelled sizes at one and five years postoperatively. The 5-year survival was equal between groups. Both prostheses demonstrated a small but significant increase in mean pressure gradients in the fifth year. Most patients enjoyed significant clinical improvement as assessed by NYHA functional class. Both bioprostheses performed very well with excellent hemodynamic parameters. The pericardial valves are a safe and appropriate choice for surgical bioprosthetic aortic valve replacement.
No takes yet. Share an insight, caveat, or question.
Manchev et al. (2023) conducted a cohort in Aortic valve disease requiring surgical aortic valve replacement (n=71). Sorin Mitroflow bovine pericardial valve vs. St. Jude Medical Epic Supra porcine valve was evaluated on Mean transprosthetic pressure gradient at 1 year (21 mm valve size) (MD 5.5, p=<0.001). The Sorin Mitroflow bovine pericardial valve demonstrated significantly lower mean transvalvular pressure gradients compared to the St. Jude Medical Epic porcine valve at 1 and 5 years postoperatively.
Synapse has enriched 10 related papers. Consider them for comparative context: